BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6935481)

  • 1. Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.
    Sluyser M; De Goeij CC; Evers SG
    J Natl Cancer Inst; 1981 Feb; 66(2):327-30. PubMed ID: 6935481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with cyclophosphamide on hormone-dependent and hormone-independent tumor cells in transplanted GR mouse mammary tumors.
    Sluyser M; Benckhuysen C
    Cancer Treat Rep; 1977 Aug; 61(5):861-7. PubMed ID: 890694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P; Briand P; Hartmann NR
    Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of mammary tumor virus in hormone-dependent and -independent mouse mammary tumor cells.
    Sluyser M; Nouwen T; Hilgers J; Calafat J
    Cancer Res; 1977 Jul; 37(7 Pt 1):1986-90. PubMed ID: 193632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
    Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
    Scheiber C; Kiss R; De Launoit Y; Frühling J
    Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor content and hormone-responsive growth of mouse mammary tumors.
    Sluyser M; Van Nie R
    Cancer Res; 1974 Dec; 34(12):3253-7. PubMed ID: 4371952
    [No Abstract]   [Full Text] [Related]  

  • 8. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT; Siemiatkowski J
    Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
    Matsuzawa A; Kaneko T; Ikeda Y
    Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biologic behavior and histology of transplanted mammary tumors in GR mice.
    Percy DH; Morris VL; MacInnes JI
    J Natl Cancer Inst; 1982 Oct; 69(4):933-8. PubMed ID: 6288995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal experimental models of breast cancer for therapeutic testing of hormones and antihormones].
    Naundorf H
    Arch Geschwulstforsch; 1988; 58(5):345-56. PubMed ID: 3060043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of testosterone by GR mouse mammary tumors.
    Abul-Hajj YJ; Kiang DT
    Cancer Res; 1982 Sep; 42(9):3510-3. PubMed ID: 7105028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
    Markaverich BM; Medina D; Clark JH
    Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115.
    Kitamura Y; Okamoto S; Uchida N; Yamaguchi K; Matsumoto K
    Cancer Res; 1978 Dec; 38(12):4711-6. PubMed ID: 719647
    [No Abstract]   [Full Text] [Related]  

  • 17. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
    Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
    Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism and enzyme activities in hormone-dependent and hormone-independent mammary adenocarcinoma in GR mice.
    Abraham S; Briand P; Hansen FN
    J Natl Cancer Inst; 1986 Jul; 77(1):233-9. PubMed ID: 3088311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary tumor virus DNA as a marker for genotypic variance within hormone-responsive GR mouse mammary tumors.
    Michalides R; Wagenaar E; Sluyser M
    Cancer Res; 1982 Mar; 42(3):1154-8. PubMed ID: 6277477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.